Cannabis in Switzerland: distinguishing clubs, pilot trials and pharmacies
Providers and products do not all have the same legal status. Product category, authorisation and access requirements matter. Private club membership does not create a general right to obtain THC cannabis.
Cannabis containing at least 1% THC generally falls under narcotics legislation. Authorised scientific trials and prescribed cannabis medicines have separate legal bases. Low-THC products remain subject to other rules according to their use; the threshold alone is not complete product authorisation.
Comparison matrix — at a glance
Channels differ first in purpose and requirements. The previous blanket price ranges are not substantiated here as collected market observations. This table establishes neither the cheapest provider nor guaranteed access.
| Channel | Price evidence | Legal status |
|---|---|---|
| Cannabis club | No substantiated comparable price survey | Private membership is not a narcotics authorisation and does not replace approval of a pilot trial. |
| Authorised pilot trial | No substantiated comparable price survey | Controlled supply within an authorised scientific study; no general market opening. |
| Medical use / pharmacy | No substantiated comparable price survey | Physicians may prescribe cannabis medicines without a FOPH exceptional authorisation. Treatment remains their responsibility. |
| Unauthorised black market | No substantiated comparable price survey | No lawful sales route for cannabis subject to narcotics legislation. |
Cannabis club
Private membership is not a narcotics authorisation and does not replace approval of a pilot trial.
check the supplier and spot suspicious club invitations
People seeking membership information; THC access requires a separate legal basis.
Check product and purpose separately; CBD and THC are not interchangeable legal categories.
- Information and questions can precede a decision.
- The name club guarantees neither lawful THC sales nor quality.
Authorised pilot trial
Controlled supply within an authorised scientific study; no general market opening.
Only people meeting the requirements of the specific study protocol.
The approved study determines products, supply locations and conditions.
- A defined, authorised scientific framework.
- Admission, available places and supply cannot be promised across studies.
Medical use / pharmacy
Physicians may prescribe cannabis medicines without a FOPH exceptional authorisation. Treatment remains their responsibility.
Patients following individual medical assessment.
Prescribed medicines; no general recreational sales.
- Medical assessment and a defined medicinal framework.
- This overview promises neither diagnosis, reimbursement nor treatment success.
Unauthorised black market
No lawful sales route for cannabis subject to narcotics legislation.
No legally assured access requirement.
Channel names do not establish origin or composition.
- No benefit or procurement route is recommended here.
- No guarantee of contents, safety, origin or lawful supply.
Frequently asked questions
Is a club automatically a lawful THC supply point?
No. Private membership replaces neither authorisation nor another legal basis.
Is there a reliable price comparison?
No traceable survey of comparable products is supplied here. Blanket prices and savings are therefore not presented as market facts.
Does possessing a small amount automatically trigger a fine?
Use and possession must be distinguished. According to the FOPH, possession of up to ten grams for personal use is not punished; this does not authorise sales.